People

Trent Reutiman

Trent is a seasoned MedTech executive with over 25 years of leadership experience spanning early-stage clinical development to global commercial execution in venture-backed, market-disruptive medical technologies. He brings a strong combination of strategic vision, operational execution, and proven success in fundraising, market expansion, clinical strategy, and medical device innovation to his role at Anaconda. Previously he was CEO of Mercator MedSystems, and Global Vice President of Commercial Operations at IDEV Technologies (acquired by Abbott for $310M). He also held executive roles at ROX Medical, Omnisonics, and RITA Medical. Trent holds a Bachelor of Science in Business from Colorado State University and an MBA from the Paul Merage School of Business at the University of California, Irvine.